GURUFOCUS.COM » STOCK LIST » Technology » Software » Chrysos Corp Ltd (ASX:C79) » Definitions » NonCurrent Deferred Liabilities

Chrysos (ASX:C79) NonCurrent Deferred Liabilities : A$0.36 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Chrysos NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Chrysos's non-current deferred liabilities for the quarter that ended in Dec. 2024 was A$0.36 Mil.

Chrysos NonCurrent Deferred Liabilities Historical Data

The historical data trend for Chrysos's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chrysos NonCurrent Deferred Liabilities Chart

Chrysos Annual Data
Trend Jun22 Jun23 Jun24
NonCurrent Deferred Liabilities
- - -

Chrysos Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial - - 0.15 - 0.36

Chrysos NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Chrysos's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Chrysos Business Description

Industry
Traded in Other Exchanges
Address
2A Venture Road, Tonsley, SA, AUS, 5064
Chrysos Corp Ltd is an Australian-based provider of novel assay services to the global mining industry through its proprietary PhotonAssay technology. The company's flagship product PhotonAssay delivers accurate, and environmentally friendly analysis of gold, silver, and complementary elements. The Group has three reportable segments namely, EMEA, Australia, and Americas, where the majority of revenue is generated from Australia. The Group generates revenue primarily from the deployment of PhotonAssay units with its customers.

Chrysos Headlines

No Headlines